4VI.F GENOMTEC S.A. ZY -10

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.5430 EUR
Close of Nov 11, 2026
0.4855 1.50
Market cap
EUR 9.27M
P/E
-
P/B
2.66x
ROE
-54.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 4VI.F undervalued?

Graham number

The Graham number of GENOMTEC S.A. ZY -10 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

GENOMTEC S.A. ZY -10 fundamental analysis

No fundamental analysis for GENOMTEC S.A. ZY -10 yet.

GENOMTEC S.A. ZY -10 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About GENOMTEC S.A. ZY -10

Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company's flagship project is the Genomtec ID, a diagnostic platform that enables the detection of pathogens, such as viruses, bacteria, and fungi, as well as genetic mutations through the analysis of biological material of patients using swabs, urine, and saliva. It also develops SNAAT chemistry for mutation detection in oncology. In addit…

Full company profile